# A Post Market Evaluation of Chronic intractaBle paIN and the Efficacy of drG stimulatiOn in the Nordic Region

> **NCT02346643** · — · TERMINATED · sponsor: **Abbott Medical Devices** · enrollment: 41 (actual)

## Conditions studied

- Chronic Pain

## Interventions

- **DEVICE:** Implantation with the commercially available Axium Neurostimulator

## Key facts

- **NCT ID:** NCT02346643
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2013-04
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 41 (ACTUAL)
- **Why stopped:** Budget Allocation Decision by Sponsor
- **Last updated:** 2019-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02346643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02346643, "A Post Market Evaluation of Chronic intractaBle paIN and the Efficacy of drG stimulatiOn in the Nordic Region". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02346643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*